JP2015049050A5 - - Google Patents

Download PDF

Info

Publication number
JP2015049050A5
JP2015049050A5 JP2013178620A JP2013178620A JP2015049050A5 JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5 JP 2013178620 A JP2013178620 A JP 2013178620A JP 2013178620 A JP2013178620 A JP 2013178620A JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5
Authority
JP
Japan
Prior art keywords
amount
test substance
urine
compounds represented
dysuria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013178620A
Other languages
English (en)
Japanese (ja)
Other versions
JP6222629B2 (ja
JP2015049050A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013178620A priority Critical patent/JP6222629B2/ja
Priority claimed from JP2013178620A external-priority patent/JP6222629B2/ja
Publication of JP2015049050A publication Critical patent/JP2015049050A/ja
Publication of JP2015049050A5 publication Critical patent/JP2015049050A5/ja
Application granted granted Critical
Publication of JP6222629B2 publication Critical patent/JP6222629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013178620A 2013-08-29 2013-08-29 排尿障害のバイオマーカー Active JP6222629B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Publications (3)

Publication Number Publication Date
JP2015049050A JP2015049050A (ja) 2015-03-16
JP2015049050A5 true JP2015049050A5 (enExample) 2016-07-28
JP6222629B2 JP6222629B2 (ja) 2017-11-01

Family

ID=52699210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013178620A Active JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Country Status (1)

Country Link
JP (1) JP6222629B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7031104B2 (ja) * 2017-09-29 2022-03-08 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカー、これを用いた検査方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法
JP7294709B2 (ja) * 2017-09-29 2023-06-20 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカーの測定方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162899A (ja) * 1983-03-08 1984-09-13 Kyoto Daiichi Kagaku:Kk β‐ヒドロキシ酪酸の定量用組成物
JP4779650B2 (ja) * 2003-12-26 2011-09-28 小野薬品工業株式会社 高活性型リゾホスファチジン酸およびそれを用いたスクリーニング方法
EP2597464B1 (en) * 2007-08-16 2015-02-25 The Regents of the University of Michigan Metabolomic profiling of prostate cancer
ES2516866T3 (es) * 2009-06-04 2014-10-31 Metanomics Health Gmbh Medios y métodos para el diagnóstico de carcinomas de próstata
WO2011087845A2 (en) * 2009-12-22 2011-07-21 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
CA2856167A1 (en) * 2011-11-11 2013-05-16 Metabolon, Inc. Biomarkers for bladder cancer and methods using the same

Similar Documents

Publication Publication Date Title
EP3264090A3 (en) Method for detecting nucleosome adducts
JP2012211908A5 (enExample)
WO2016044338A3 (en) Methods and systems for diagnosing sleep disorders
CA2863393A1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
EP2759259A3 (en) Apparatus and method for measuring stress based on a behavior of a user
RU2015155792A (ru) Визуализация неврологоческого заболевания
JP2014144959A5 (enExample)
BR112013006764A2 (pt) método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente
WO2012047899A3 (en) Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
WO2012110878A3 (en) Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity
CY1123265T1 (el) Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς
EA201290793A1 (ru) Зонд для определения границ между веществами
JP2010256190A5 (enExample)
EA201490946A1 (ru) Способ количественной оценки лечения рака
JP2013504766A5 (enExample)
MX2012007009A (es) Método para diagnosticar un tumor maligno.
JP2018536170A5 (enExample)
RU2016149127A (ru) Калибровка уровня аналита с использованием базисного уровня аналита
JP2015049050A5 (enExample)
WO2012037199A3 (en) Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
JP2010526995A5 (enExample)
WO2015006657A8 (en) Method for the diagnosis and prognosis of cancer
EP3665694A4 (en) Systems and methods for improving disease diagnosis using measured analytes
WO2016164467A8 (en) Imaging device and method for detection of disease
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia